🧪 Exciting News! We’ve launched our New Lab Program - empowering innovation with cutting-edge research facilities. <a href="https://cellculturecollective.com/new-lab-program/" target="_blank">Explore Now! 🔬</a>

Defined Bioscience® FGF2 Screening Kit

$250.00

Defined Bioscience’s FGF2 Screening Kit offers multiple animal-free, recombinantly expressed FGF2 variants for research use. This kit includes four FGF2 variants in easy-to-use aliquots of 10 or 50 µg each, including thermostable and native sequences. Previous research has shown the value of cross-species homologs in cell culture applications, offering opportunities to use these growth factors in improving workflows across human and non-human cell line culture.

The kit includes 10- or 50-ug aliquots of each of the following four proteins:

  • FGF2-G3 (human): G3 mutations applied to the native FGF2 sequence for sapiens, human (also provided by Defined Bioscience as Cat # LSR-101)
  • FGF2-G3 (bovine/porcine): G3 mutations applied to the native FGF2 sequences for taurus and S. scrofa, domesticated cattle and pig (also provided by Defined Bioscience as Cat # LSR-302)
  • FGF2 (chicken): the native FGF2 sequence for gallus, domestic chicken (also provided by Defined Bioscience as Cat # LSR-202)
  • FGF2 (tuna): the native FGF2 sequence for albacares, yellowfin tuna (also provided by Defined Bioscience as Cat # LSR-120)

Contact us for larger quantities to get a quote.

SKU Defined Bioscience® FGF2 Screening Kit Categories ,

Product Details

Biological Activity

FGF2-G3 (human and bovine/porcine) has an expected EC50 of less than 1 ng/mL, and FGF2 (chicken tuna) has an expected EC50 of less than 2 ng/mL, as determined in-house for all lots by an NIH-3T3 cell proliferation assay.

General Use

Each FGF2 variant included in this kit is supplied as a 1 mg/mL solution in storage buffer that can be incorporated into most standard buffer formulations as needed for downstream use. Dosage testing is recommended for optimal performance.

Related Products

Customer Reviews

Latest Articles